Lopinavir-Ritonavir No Benefit in Patients Admitted With COVID-19

WEDNESDAY, Oct. 7, 2020 -- Lopinavir-ritonavir is not associated with reductions in 28-day mortality or duration of hospital stay among patients admitted to the hospital with COVID-19, according to a study published online Oct. 5 in The...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news